SAMSCA (Otsuka America Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the SAMSCA drug offered from Otsuka America Pharmaceutical, Inc.. This Vasopressin V2 Receptor Antagonist [EPC],Vasopressin V2 Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Otsuka America Pharmaceutical, Inc. |
NON-PROPRIETARY NAME: | tolvaptan |
SUBSTANCE NAME: | TOLVAPTAN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Vasopressin V2 Receptor Antagonist [EPC],Vasopressin V2 Receptor Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2009-05-19 |
END MARKETING DATE: | 0000-00-00 |
SAMSCA HUMAN PRESCRIPTION DRUG Details:
Item Description | SAMSCA from Otsuka America Pharmaceutical, Inc. |
LABELER NAME: | Otsuka America Pharmaceutical, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 15(mg/1) |
START MARKETING DATE: | 2009-05-19 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 59148-020_fd141765-4d48-4b7e-aed1-3f2a72713c47 |
PRODUCT NDC: | 59148-020 |
APPLICATION NUMBER: | NDA022275 |
Other TOLVAPTAN Pharmaceutical Manufacturers / Labelers: